Boehringer Ingelheim is partnering with online platform Kaggle to challenge the internet to solve a complex biological problem.
Pharmaceutical company Boehringer Ingelheim is looking to create a model that can help scientists accurately predict the biological response of molecules. For assistance, it’s turning to an online science community by partnering with Kaggle. The crowd-sourced competition asks participants to come up with an algorithm that can predict a biological endpoint to a molecule by only knowing its structure and composition. Contributors have until 15 June, 2012, to come up with a working model and share a prize pool of $20,000.
Kaggle gamifies science and has already successfully helped companies and researchers solve problems through holding competitions with cash incentives. Dr. James Baxter, Vice President of Development at Boehringer Ingelheim, commented that:
[We're] proud to be the first pharmaceutical company to use the Kaggle platform as a way to drive innovative solutions to this scientific challenge. We are excited to encourage a dialog on new ideas that may ultimately bring more health to patients and families.